Form 4 for MET MetLife
Accepted 2024-03-14 00:00:00 ET · period of report 2024-03-13 · accession 0001099219-24-000076 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-14 | 2024-03-13 | MET | TADROS RAMY | Pres, U.S. Business | S - Sale | $71.90 | -4,026 | 147.0K | -3% | -$289.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-13 | S | D | 4,026 | $71.90 | 146,981 | D | — | — | (F2) The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $71.85 to $72.00, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. |